ARRAY BIOPHARMA - Home
 
 
Publications   |   Patents   |   Posters & Presentations

Keyword Search
 
Below are scientific posters that have been presented at scientific conferences and that relate to Array's proprietary research programs or research collaborations with other biotechnology or pharmaceutical companies.
AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics
11/17/2005
A First in Human Dose-Ranging Study to Assess the Pharmacokinetics, Pharmacodynamics, and Toxicities of MEK Inhibitor, ARRY-142886 (AZD6244) in Patients with Advanced Solid Malignancies
LQM Chow, et. al.
Open PDF File >>
AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics
11/16/2005
4-(4-Bromo-2-fluorophenylamino-1-methyl-pyridin-2(1H)ones: Potent and Selective MEK 1,2 Inhibitors
Eli M. Wallace, et. al.
Open PDF File >>
AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics
11/15/2005
In Vivo Anti-Tumor Activity of ARRY-334543, a Small Molecule Inhibitor of EGFR and ErbB-2
Tracy Pheneger, et. al.
Open PDF File >>
American College of Rheumatology
11/14/2005
Characterization of a Potent MEK Inhibitor in In Vivo Models of Inflammatory Disease
Jed Pheneger, et. al.
Open PDF File >>
International Society for the Study of Xenobiotics
10/27/2005
Pharmacokinetics and Metabolic Stability of Two Novel Inhibitors of HCV NS3/4 Protease in Rats, Dogs and Monkeys
Rob Rieger, et. al.
Open PDF File >>
230th ACS National Meeting
8/31/2005
Charged Thiamine Mimetics as Inhibitors of Enzyme Transketolase
Indrani Gunawardana, et. al.
Open PDF File >>
230th ACS National Meeting
8/31/2005
Non-Charged Thiamine Analogues as Inhibitors of Enzyme Transketolase
Allen A. Thomas, et. al.
Open PDF File >>
230th ACS National Meeting
8/31/2005
Potent and Selective Thiamine Antagonists That Inhibit Transketolase
Todd Romoff, et. al.
Open PDF File >>
7th World Congress on Inflammation Meeting
8/23/2005
In Vivo Activity of Potent MEK Inhibitors in Two Models of Inflammatory Disease
Patrice Lee, et. al.
Open PDF File >>
20th International Congress of Heterocyclic Chemistry
8/3/2005
Synthesis of Non-Charged Thiamine Mimetics as Inhibitors of Transketolase
Tomas Kaplan, et. al.
Open PDF File >>
19th Annual Symposia of the Protein Society
8/2/2005
Kinetic Characterization of Phosphorylated Wild-Type MKK6 and Constitutively Activated Mutant MKK6
Josh Ballard, et. al.
Open PDF File >>
Gordon Research Conference
7/17/2005
Array BioPharma: Oncology Pipeline
James Winkler, et. al.
Open PDF File >>
PharmSciFair
6/13/2005
Human Hepatic Stability Screening: A Simplified Higher Throughput Assay and Evaluation of Different Hepatocyte Preparations
Gary Hingorani, et. al.
Open PDF File >>
Bioorganic Chemistry Gordon Research Conference
6/12/2005
Non-Charged Thiamine Antagonists That Inhibit Transketolase
Jason De Meese, et. al.
Open PDF File >>
CTF International Consortium for the Molecular Biology of NF1, NF2 and Schwannomatosis
6/5/2005
Validation and Use of a Biomarker for Development of the MEK 1 / 2 Inhibitor ARRY-142886 (AZD6244)
T.C. Yeh, et. al.
Open PDF File >>
ASCO Annual Meeting
5/15/2005
Validation and Use of a Biomarker for Clinical Development of the MEK 1 / 2 Inhibitor ARRY-142886 (AZD6244)
Mike Doyle, et. al.
Open PDF File >>
AACR Annual Meeting
4/18/2005
ARRY-333786, a Potent, Selective, Orally Active, Small Molecule Inhibitor of ErbB-2
Bryan Bernat, et. al.
Open PDF File >>
AACR Annual Meeting
4/18/2005
ARRY-334543, a Potent, Orally Active, Small Molecule Inhibitor of EGFR and ErbB-2
Greg Miknis, et. al.
Open PDF File >>
ACS National Meeting
3/13/2005
Finding drugs within chemistry space: Impact of the clinical development process
James F. Blake
Open PDF File >>

 

 
 
Email this page
Printer friendly version